When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OYST - Protalix Fabry Positive Data And Other News: The Good Bad And Ugly Of Biopharma
Oyster Point Pharma Inc.
Protalix Reports Positive Topline Results for Phase III Data
Protalix BioTherapeutics Inc. (PLX) announced positive topline data from Phase III BRIDGE clinical trial of its lead drug candidate PRX-102. This Phase III study was an open label, single arm switch-over 12 month long study aiming to evaluate the safety and efficacy of pegunigalsidase alfa, 1 mg/kg infused every two weeks, in Fabry patients previously treated with agalsidase alfa, for at least two years and on a stable dose for at least six months. The data showed substantial improvement in renal function in both